{"transactions":[{"id":900573,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant Shares (Series A-2)","published_at":"2026-02-17T13:35:17.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":18750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A-1 Warrants and Series A-2 Warrants (the \"Common Warrants\") will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Common Warrants (the \"Stockholder Approval Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series A-2 Warrants expire on the earlier of (i) the sixty-month anniversary of the Stockholder Approval Date and (ii) thirty days following the date the Company publicly announces that it has received U.S. Food and Drug Administration approval for its Acclaim cochlear implant (the \"Series A-2 Milestone Event\")."}],"balance_after":18750000,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":18750000},"source":{"system":"sec-edgar","filing":"0001104659-26-016182","document":"tm266585-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000110465926016182/tm266585-1_4seq1.xml","form_type":"4"}},{"id":900572,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant Shares (Series A-1)","published_at":"2026-02-17T13:35:17.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":11250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A-1 Warrants and Series A-2 Warrants (the \"Common Warrants\") will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Common Warrants (the \"Stockholder Approval Date\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-1 Warrants expire on the earlier of (i) the twenty-four month anniversary of the Stockholder Approval Date and (ii) thirty days following the date the Company publicly announces that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration for its Acclaim cochlear implant (the \"Series A-1 Milestone Event\")."}],"balance_after":11250000,"derivative":{"exercise_price":0.4,"underlying":"Class A Common Stock","underlying_shares":11250000},"source":{"system":"sec-edgar","filing":"0001104659-26-016182","document":"tm266585-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000110465926016182/tm266585-1_4seq1.xml","form_type":"4"}},{"id":900571,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-02-17T13:35:17.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":18750000,"price":0.4,"value":7500000.0,"ownership":{"direct":true},"balance_after":21703607,"source":{"system":"sec-edgar","filing":"0001104659-26-016182","document":"tm266585-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000110465926016182/tm266585-1_4seq1.xml","form_type":"4"}},{"id":1045714,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 6/26/2025 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 6/26/2025 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":750000,"derivative":{"exercise_price":1.48,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045713,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F11","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 6/26/2025 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 6/26/2025 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":1.48,"expiration_date":"2027-06-26","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045712,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":750000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 3/11/2025 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 3/11/2025 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":750000,"derivative":{"exercise_price":1.35,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045711,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F10","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 3/11/2025 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 3/11/2025 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":1.35,"expiration_date":"2028-03-11","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045710,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 12/11/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 12/11/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":2.2,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045709,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 12/11/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 12/11/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":2.2,"expiration_date":"2026-08-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045708,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 8/27/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 8/27/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":2.97,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045707,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 8/27/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 8/27/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":2.97,"expiration_date":"2026-08-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045706,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 7/22/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 7/22/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":250000,"derivative":{"exercise_price":2.25,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045705,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 7/22/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 7/22/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":2.25,"expiration_date":"2026-02-27","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045704,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 5/23/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 5/23/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":250000,"derivative":{"exercise_price":3.04,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045703,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 5/23/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally granted on 5/23/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":3.04,"expiration_date":"2026-02-27","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045702,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally purchased on 2/27/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally purchased on 2/27/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":1.24,"expiration_date":"2028-12-31","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1045701,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-09-08T17:17:48.000Z","date":"2025-09-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":500000,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally purchased on 2/27/2024 and is fully exercisable."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The two reported transactions involved an amendment of an outstanding warrant, resulting in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally purchased on 2/27/2024 and is fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":1.24,"expiration_date":"2026-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-25-015411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325015411/form4.xml","form_type":"4"}},{"id":1090520,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-07-08T10:37:33.000Z","date":"2025-06-26","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the promissory note issuance effective March 6, 2025 and the closing of the final funding on June 26, 2025, this warrant was issued to GAT Funding, LLC, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on July 2, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":750000,"derivative":{"exercise_price":1.48,"exercise_date":"2025-06-26","expiration_date":"2027-06-26","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-012617","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325012617/form4.xml","form_type":"4"}},{"id":1207516,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2025-03-13T16:06:56.000Z","date":"2025-03-11","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the promissory note issuance effective March 6, 2025 and the closing of the initial funding on March 11, 2025, this warrant was issued to GAT Funding, LLC, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on March 12, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":750000,"derivative":{"exercise_price":1.35,"exercise_date":"2025-03-11","expiration_date":"2028-03-11","underlying":"Class A Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001062993-25-005363","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299325005363/form4.xml","form_type":"4"}},{"id":1328291,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-12-17T16:42:31.000Z","date":"2024-12-11","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the Issuer's draw under the promissory note issued on August 27, 2024 to GAT Funding, LLC, this warrant was issued as a commitment fee, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on December 17, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":2.2,"exercise_date":"2024-12-11","expiration_date":"2026-08-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-24-020770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299324020770/form4.xml","form_type":"4"}},{"id":1419811,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-08-29T16:06:32.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the Issuer's draw under the promissory note issued on August 27, 2024 to GAT Funding, LLC, this warrant was issued as a commitment fee, as described in more detail in Item 1.01 of the Issuer's 8-K as filed with the SEC on August 28, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":2.97,"exercise_date":"2024-08-27","expiration_date":"2026-08-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-24-015872","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299324015872/form4.xml","form_type":"4"}},{"id":1449272,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-07-24T16:43:08.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the Issuer's draw under the promissory note issued in February 2024 to GAT Funding, LLC, this warrant was issued as a commitment fee, as described in more detail in Exhibit 10.1 of the Issuer's 10-Q as filed with the SEC on May 15, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":250000,"derivative":{"exercise_price":2.25,"exercise_date":"2024-07-22","expiration_date":"2026-02-27","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-24-014054","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299324014054/form4.xml","form_type":"4"}},{"id":1500123,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-05-28T16:13:49.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the Issuer's draw under the promissory note issued in February 2024 to GAT Funding, LLC, this warrant was issued as a commitment fee, as described in more detail under Item 1.01 in the Issuer's 8-K as filed with the SEC on May 24, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":250000,"derivative":{"exercise_price":3.04,"exercise_date":"2024-05-23","expiration_date":"2026-02-27","underlying":"Class A Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001062993-24-011337","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299324011337/form4.xml","form_type":"4"}},{"id":1602616,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-03-04T17:19:24.000Z","date":"2024-02-27","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"GAT Funding LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":500000,"derivative":{"exercise_price":1.24,"exercise_date":"2024-02-27","expiration_date":"2026-02-26","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-24-005235","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299324005235/form4.xml","form_type":"4"}},{"id":1723572,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-12-04T16:57:21.000Z","date":"2023-11-20","kind":"other","planned":false,"acquired":false,"shares":100000,"price":10,"value":1000000.0,"ownership":{"direct":false,"nature":"GAT Funding LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This Amendment reports the cancellation of the purchase of 100,000 shares of Series A Preferred Stock on November 20, 2023 by GAT Funding, LLC (\"GAT\"), which was reported in the original Form 4. The purchase of the reported Series A Preferred Stock was cancelled due to a determination that certain conditions precedent to the purchase of the Series A Preferred Stock in the agreement had not been met."},{"field":"shares","element":"transactionShares","label":"F3","text":"This Amendment reports the cancellation of the purchase of 100,000 shares of Series A Preferred Stock on November 20, 2023 by GAT Funding, LLC (\"GAT\"), which was reported in the original Form 4. The purchase of the reported Series A Preferred Stock was cancelled due to a determination that certain conditions precedent to the purchase of the Series A Preferred Stock in the agreement had not been met."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This Amendment reports the cancellation of the purchase of 100,000 shares of Series A Preferred Stock on November 20, 2023 by GAT Funding, LLC (\"GAT\"), which was reported in the original Form 4. The purchase of the reported Series A Preferred Stock was cancelled due to a determination that certain conditions precedent to the purchase of the Series A Preferred Stock in the agreement had not been met."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This Amendment reports the cancellation of the purchase of 100,000 shares of Series A Preferred Stock on November 20, 2023 by GAT Funding, LLC (\"GAT\"), which was reported in the original Form 4. The purchase of the reported Series A Preferred Stock was cancelled due to a determination that certain conditions precedent to the purchase of the Series A Preferred Stock in the agreement had not been met."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":1000000,"derivative":{"exercise_price":11.5,"underlying":"Class A Common Stock","underlying_shares":869565},"source":{"system":"sec-edgar","filing":"0001062993-23-021838","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299323021838/form4a.xml","form_type":"4/A","original_submission_date":"2023-11-22"}},{"id":1730951,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-11-22T16:11:45.000Z","date":"2023-11-20","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":10,"value":1000000.0,"ownership":{"direct":false,"nature":"GAT Funding LLC"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The original filing on October 3, 2023 contained a calculation error and the amount shown in column 7 now reflects the correct number of shares\nissuable upon conversion."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"GAT Funding, LLC is an entity controlled by the Reporting Person."}],"balance_after":1100000,"derivative":{"exercise_price":11.5,"underlying":"Class A Common Stock","underlying_shares":956522},"source":{"system":"sec-edgar","filing":"0001062993-23-021360","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299323021360/form4.xml","form_type":"4"}},{"id":1766856,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2023-10-03T18:32:58.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":true,"shares":869565,"price":10,"value":8695650.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents the conversion of Reporting Person's $10,000,000 Envoy Bridge Note into shares of Series A Preferred Stock at $10 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Fully exercisable and there is no expiration date."}],"balance_after":869565,"derivative":{"exercise_price":11.5,"underlying":"Class A Common Stock","underlying_shares":869565},"source":{"system":"sec-edgar","filing":"0001062993-23-018900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299323018900/form4.xml","form_type":"4"}},{"id":1766855,"issuer":{"id":7161,"kind":"organization","name":"Envoy Medical, Inc."},"owners":[{"id":66171,"kind":"person","name":"TAYLOR GLEN A","position":1,"cik":"0001213971","reported_name":"TAYLOR GLEN A","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"$10,000,000 Convertible Note","published_at":"2023-10-03T18:32:58.000Z","date":"2023-09-29","kind":"exercise","planned":false,"acquired":false,"shares":1000000,"price":10,"value":10000000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents the conversion of Reporting Person's $10,000,000 Envoy Bridge Note into shares of Series A Preferred Stock at $10 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable and there is no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Fully exercisable and there is no expiration date."}],"balance_after":0,"derivative":{"underlying":"Series A Preferred Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001062993-23-018900","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213971/000106299323018900/form4.xml","form_type":"4"}}]}